Voloridge Investment Management LLC Purchases New Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Voloridge Investment Management LLC purchased a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,664,918 shares of the pharmacy operator's stock, valued at approximately $15,534,000. Voloridge Investment Management LLC owned about 0.19% of Walgreens Boots Alliance as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Golden State Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at $26,000. Riverview Trust Co lifted its holdings in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,590 shares during the period. Colonial Trust Co SC lifted its holdings in Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,297 shares during the period. Venturi Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter worth about $28,000. Finally, Independence Bank of Kentucky bought a new position in shares of Walgreens Boots Alliance in the 4th quarter worth about $39,000. Institutional investors own 58.59% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on WBA shares. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Finally, Wall Street Zen assumed coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating for the company. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of "Hold" and a consensus target price of $10.59.

Insider Transactions at Walgreens Boots Alliance

In related news, Chairman Stefano Pessina purchased 832,258 shares of the firm's stock in a transaction on Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the acquisition, the chairman now owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock traded down $0.02 during mid-day trading on Thursday, reaching $11.18. 2,777,032 shares of the company's stock traded hands, compared to its average volume of 20,799,175. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $16.34. The firm has a 50 day moving average price of $11.03 and a two-hundred day moving average price of $10.45. The firm has a market capitalization of $9.66 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business's quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.20 EPS. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.